Decreased S100-beta protein in schizophrenia: preliminary evidence. (Q33906095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Decreased S100-beta protein in schizophrenia: preliminary evidence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

W F Gattaz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D R Lara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H Elkis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L V Portela

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C A Gonçalves

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A B Tort

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Henna

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

published in

Schizophrenia Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

91-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

Intracerebroventricular injection of phospholipase A2 inhibits apomorphine-induced locomotion in rats

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Phospholipase A2 and the hypofrontality hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Decreased phospholipase A2 activity in Alzheimer brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

A Negative Symptom Rating Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. Case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Acute exacerbation of multiple sclerosis increases plasma levels of S-100 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Elevated PLA2 activity in schizophrenics and other psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

The S100 family of EF-hand calcium-binding proteins: functions and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Studies of neuroimmune markers in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Neuronal death: is there a role for astrocytes?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Secretion of S-100 from rat C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

From neuropathology to neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

Elevated plasma levels of S-100b protein in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

P11, a unique member of the S100 family of calcium-binding proteins, interacts with and inhibits the activity of the 85-kDa cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

The S100 protein family: history, function, and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900146-2

7 January 2021

10.1016/S0920-9964(99)00146-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10858627%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference